3-(Piperidin-1-yl)propyl 4-amino-5-chloro-2-methoxybenzoate hydrochloride

Catalog No. :
ACKDNZ105
CAS No. :
149719-06-2
Molecular Formula :
C16H24Cl2N2O3
Molecular Weight :
363.29

IUPAC Name:3-(piperidin-1-yl)propyl 4-amino-5-chloro-2-methoxybenzoate hydrochloride

3-(Piperidin-1-yl)propyl 4-amino-5-chloro-2-methoxybenzoate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg98%$81.00Login to see priceIn stockInquiry
25mg98%$168.00Login to see priceIn stockInquiry
50mg98%$285.00Login to see priceIn stockInquiry
100mg98%$484.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Piperidin-1-yl)propyl 4-amino-5-chloro-2-methoxybenzoate hydrochloride
IUPAC Name3-(piperidin-1-yl)propyl 4-amino-5-chloro-2-methoxybenzoate hydrochloride
Molecular FormulaC16H24Cl2N2O3
Molecular Weight363.29
SMILESO=C(OCCCN1CCCCC1)C2=CC(Cl)=C(N)C=C2OC.[H]Cl
InChI KeyQLZLBYYNMGQIAR-UHFFFAOYSA-N
Synonym3-(Piperidine-1-yl)propyl 4-amino-5-chloro-2-methoxybenzoate hydrochloride | 4-amino-5-chloro-2-methoxybenzoic acid 3-(1-piperidinyl)propyl ester hydrochloride | ZFA71906 | Benzoic acid, 4-amino-5-chloro-2-methoxy-, 3-(piperidine-1-yl)propyl ester, hydroc
CAS No.149719-06-2
PubChem CID182592

Synthetic Route by SureRoute

1. ACKDNZ105 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKDNZ105 route product structure diagram
    ACKDNZ105149719-06-2 In Stock
Inquiry

2. ACKDNZ105 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAKBV489 route compound structure diagram
    ACAKBV4897206-70-4 In Stock
  2. Plus
  3. ACMPIF584 route compound structure diagram
    ACMPIF584104-58-5 In Stock
  4. Then
  5. ACKDNZ105 route product structure diagram
    ACKDNZ105149719-06-2 In Stock
Inquiry

Comments (0)